Monica Lopez-Guerra was graduated in Biology in University of Barcelona in 2004. In 2009, she received her PhD with the thesis entitled “Therapeutic strategies in lymphoid malignancies”, under the supervision of dr. Dolors Colomer, with 3 papers published in leading journals in hematology and oncology. In 2011, she obtained a postdoctoral grant from Asociación Española contra el Cáncer (AECC) to work on the functional and therapeutic validation of the recurrent mutations described in the ICGC CLL Project.
Nowadays, Monica Lopez-Guerra holds a position as a Senior Specialist in the Hematopathology Section, pathology Department, of Hospital Clinic de Barcelona. She is in charge of the molecular biology area, specialized in the diagnosis and measurement of the minimal residual disease in leukemia and lymphoma. She is also in charge of the Quality assessment of the section. In addition, she is a member of the research group “Experimental Therapeutic Targets in lymphoid malignancies”, leaded by Dr.Dolors Colomer, at the IDIBAPS. The research line of the group focuses on the preclinical evaluation of the drug response and on the characterization of the mechanism of action of experimental or newly approved drugs for the treatment of lymphoid malignancies, basically focused on chronic lymphocytic leukemia
(CLL) and the mantle cell lymphoma (MCL). She has published 51 papers in leading journals, most of them in the first decile of their respective knowledge areas.